The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Li, Ziyao ^a   Ren, Min ^a   Tian, Jiawei ^a   Jiang, Shuangquan ^a   Liu, Yujie ^a   Zhang, Lei ^a   Wang, Zhenzhen ^a   Song, Qianqian ^a   Liu, Chong ^a   Wu, Tong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASAL LIKE BREAST CANCER; CANCER GRADING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOMAMMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PHENOTYPE; TRIPLE NEGATIVE BREAST CANCER; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME; CARCINOMA; DIAGNOSTIC IMAGING; ECHOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATIN-6; LOGISTIC MODELS; MIDDLE AGED; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRIPLE NEGATIVE BREAST NEOPLASMS; ULTRASONOGRAPHY;

EID: 84923882200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114820     Document Type: Article

References (30)

1. Choccalingam C, Rao L, Rao S (2012) Clinico-Pathological Characteristics of Triple Negative and Non Triple Negative High Grade Breast Carcinomas with and Without Basal Marker (CK5/6 and EGFR) Expression at a Rural Tertiary Hospital in India. Breast Cancer (Auckl) 6: 21-29. doi: 10.4137/BCBCR. S8611 PMID: 22346359
2. Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Pathology 41: 40-47. doi: 10.1080/00313020802563510 PMID: 19089739
3. Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, et al. (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 59: 729-735. PMID: 16556664
4. Dogan BE, Turnbull LW(2012) Imaging of triple-negative breast cancer. Ann Oncol 23 Suppl 6: vi23-29. PMID: 23012298
5. Rao C, Shetty J, Prasad KH (2013) Immunohistochemical profile and morphology in triple - negative breast cancers. J Clin Diagn Res 7: 1361-1365. doi: 10.7860/JCDR/2013/5823.3129 PMID: 23998066
6. Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, et al. (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19: 264-271. PMID: 16341146
7. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, et al. (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367-5374. PMID: 15328174
8. Cakir A, Gonul II, Uluoglu O (2012) A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas. Diagn Pathol 7: 145. doi: 10.1186/1746-1596-7-145 PMID: 23082819
9. Au-Yong IT, Evans AJ, Taneja S, Rakha EA, Green AR, et al. (2009) Sonographic correlations with the new molecular classification of invasive breast cancer. Eur Radiol 19: 2342-2348. doi: 10.1007/s00330-009-1418-2 PMID: 19440719
10. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377. PMID: 13499785
11. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, et al. (1990) Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50: 7057-7061. PMID: 2208173
12. Guerra I, Algorta J, Diaz de Otazu R, Pelayo A, Farina J (2003) Immunohistochemical prognostic index for breast cancer in young women. Mol Pathol 56: 323-327. PMID: 14645694
13. Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, et al. (2003) Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer 98: 2547-2553. PMID: 14669272
14. Adler DD, Carson PL, Rubin JM, Quinn-Reid D (1990) Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 16: 553-559. PMID: 2238263
15. Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, et al. (2010) Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 20: 1111-1117. doi: 10.1007/s00330-009-1656-3 PMID: 19898850
16. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, et al. (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196: 123-134. PMID: 7784555
17. Rakha EA, Ellis IO (2007) An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60: 1300-1306. PMID: 17630399
18. Krizmanich-Conniff KM, Paramagul C, Patterson SK, Helvie MA, Roubidoux MA, et al. (2012) Triple receptor-negative breast cancer: imaging and clinical characteristics. AJR Am J Roentgenol 199: 458-464. doi: 10.2214/AJR.10.6096 PMID: 22826413
19. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, et al. (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13: 4429-4434. PMID: 17671126
20. Boisserie-Lacroix M, Macgrogan G, Debled M, Ferron S, Asad-Syed M, et al. (2013) Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Oncologist 18: 802-811. doi: 10.1634/theoncologist.2013-0380 PMID: 23821326
21. Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H, et al. (2013) Correlation between imaging and molecular classification of breast cancers. Diagn Interv Imaging 94: 1069-1080. doi: 10.1016/j.diii.2013.04.010 PMID: 23867597
22. Billar JA, Dueck AC, Stucky CC, Gray RJ, Wasif N, et al. (2010) Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol 17 Suppl 3: 384-390. doi: 10.1245/s10434-010-1260-4 PMID: 20853062
23. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, et al. (2007) Prognostic markers in triple-negative breast cancer. Cancer 109: 25-32. PMID: 17146782
24. Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52: 108-118. doi: 10.1111/j.1365-2559.2007.02889.x PMID: 18171422
25. Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, et al. (2010) Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol 23: 123-133. doi: 10.1038/modpathol.2009.145 PMID: 19855377
26. Luparia A, Mariscotti G, Durando M, Ciatto S, Bosco D, et al. (2013) Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI. Radiol Med 118: 1119-1136. doi: 10.1007/s11547-013-0941-z PMID: 23801389
27. Fornage BD, Sneige N, Faroux MJ, Andry E (1990) Sonographic appearance and ultrasound-guided fine-needle aspiration biopsy of breast carcinomas smaller than 1 cm3. J Ultrasound Med 9: 559-568. PMID: 2231854
28. Fornage BD, Lorigan JG, Andry E (1989) Fibroadenoma of the breast: sonographic appearance. Radiology 172: 671-675. PMID: 2549564
29. Ueno E, Tohno E, Soeda S, Asaoka Y, Itoh K, et al. (1988) Dynamic tests in real-time breast echography. Ultrasound Med Biol 14 Suppl 1: 53-57. PMID: 3055603
30. Cole-Beuglet C, Soriano RZ, Kurtz AB, Goldberg BB (1983) Fibroadenoma of the breast: sonomammography correlated with pathology in 122 patients. AJR Am J Roentgenol 140: 369-375. PMID: 6600356